Amazon.com Inc’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,457,055
Closed -$5.65M 7
2026
Q1
$5.65M Hold
1,457,055
0.21% 5
2025
Q4
$2.84M Hold
1,457,055
0.08% 5
2025
Q3
$1.23M Hold
1,457,055
0.05% 5
2025
Q2
$1.06M Hold
1,457,055
0.04% 7
2025
Q1
$1.25M Hold
1,457,055
0.05% 7
2024
Q4
$2.45M Hold
1,457,055
0.09% 7
2024
Q3
$4.15M Hold
1,457,055
0.19% 8
2024
Q2
$3.41M Hold
1,457,055
0.14% 8
2024
Q1
$4.28M Hold
1,457,055
0.2% 8
2023
Q4
$4.36M Hold
1,457,055
0.11% 7
2023
Q3
$4.6M Hold
1,457,055
0.11% 7
2023
Q2
$5.64M Hold
1,457,055
0.18% 7
2023
Q1
$4.04M Hold
1,457,055
0.14% 6
2022
Q4
$2.62M Hold
1,457,055
0.08% 6
2022
Q3
$3.09M Hold
1,457,055
0.06% 6
2022
Q2
$3.92M Hold
1,457,055
0.09% 6
2022
Q1
$6.32M Hold
1,457,055
0.07% 6
2021
Q4
$7.55M Hold
1,457,055
0.04% 7
2021
Q3
$8.95M Hold
1,457,055
1.83% 4
2021
Q2
$14.7M Buy
+1,457,055
New +$15.8M 3.85% 3

Other funds holding NAUT

Amazon.com Inc's NAUT Position: Q2 2026 in Review

Amazon.com Inc sold out of Nautilus Biotechnolgy (NAUT) in Q2 2026, closing a stake of 1,457,055 shares — an estimated $5.65M sold.

Amazon.com Inc first reported a position in NAUT in Q2 2021 and held it in 20 quarters. The position peaked at $14.7M in Q2 2021. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Amazon.com Inc reported no remaining Nautilus Biotechnolgy position as of Q2 2026 after selling out during the quarter.
  • Amazon.com Inc sold 1,457,055 Nautilus Biotechnolgy shares in Q2 2026, an estimated $5.65M.
  • Amazon.com Inc first reported a position in Nautilus Biotechnolgy in Q2 2021 and held it in 20 quarters.
  • Amazon.com Inc's Nautilus Biotechnolgy position peaked at $14.7M in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Amazon.com Inc's 13F filing for Q2 2026, filed 6 Aug 2026.